← Back to Search

Intervention Arm for Stroke

N/A
Waitlist Available
Led By Brian T Jankowitz, MD
Research Sponsored by Viz.ai, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects with stroke symptoms who undergo CT brain imaging.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment
Awards & highlights

Study Summary

This trial will assess whether the Viz RECRUIT software can accurately identify subjects who have had a stroke event, as determined by standard imaging assessments.

Eligible Conditions
  • Stroke

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance

Trial Design

2Treatment groups
Active Control
Group I: Control ArmActive Control1 Intervention
Subjects enrolled as part of the ENRICH Trial prior to Viz RECRUIT software activation
Group II: Intervention ArmActive Control1 Intervention
Subject CT images assessed by Viz RECRUIT software in "real time" analysis All subjects in which the Viz RECRUIT software is utilized will be identified per cohort described below per PI confirmation of ENRICH Trial status/Study ID. Cohort A: Subjects with imaging data Cohort B: Subjects with imaging data and ultimately enrolled as part of the ENRICH Trial

Find a Location

Who is running the clinical trial?

Viz.ai, Inc.Lead Sponsor
3 Previous Clinical Trials
2,000 Total Patients Enrolled
Nico CorporationIndustry Sponsor
3 Previous Clinical Trials
440 Total Patients Enrolled
Brian T Jankowitz, MDPrincipal InvestigatorThe Cooper Health System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~952 spots leftby Apr 2025